Answer
Emicizumab (Hemlibra) is contraindicated in patients with hypersensitivity to emicizumab or any of its excipients.
Sources for this answer
- Hemlibra 30 mg/mL and 150 mg/mL Solution for InjectionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 17Document updated
Sources checked